Ahmad Awada, MD
Free University
Brussels, Belgium

M.H. Cullen, MD
University Hospital Birmingham
Birmingham, United Kingdom

J. Peter Donnelly, PhD
St. Raboud University Medical Center
Nijmegen, The Netherlands

Ronald Feld, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Helen Giamarellou, MD, PhD
National and Kapodistrian
University of Athens
Athens, Greece

Raoul Herbrecht, MD
Hôpital de Hautepierre
Strasbourg, France

Georg Maschmeyer, MD
Ernst von Bergmann Clinic
Postdam, Germany

Marcio Nucci, MD
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil

Kenneth V.I. Rolston, MD
University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Maria Elena Santolaya, MD
Chilean Society of Infection
Santiago, Chile

Martin Tattersall, MD
University of Sydney
Sydney, Australia

John R. Wingard, MD
University of Florida
Gainesville, Florida, United States

Emilio Bouza, MD
University General Hospital
Madrid, Spain

Enric Carreras, MD
Clinic Hospital
Barcelona, Spain

Rafael de la Cámara, MD
Princess Hospital
Madrid, Spain

Javier Garau, MD
Common Ground Hospital
Tarrasa, Spain

José A. García Rodríguez, MD
University Hospital
Salamanca, Spain

Miguel Gobernado, MD
University Hospital
Valencia, Spain

Rafael de la Cámara, MD
Princess Hospital
Madrid, Spain

Elio Castagnola, MD
G. Gaslini Children’s Hospital
Genova, Italy

J. Peter Donnelly, PhD
St. Raboud University Medical Center
Nijmegen, The Netherlands

Hermann Einsele, MD
University of Wurzburg
Wurzburg, Germany

Jean A. Klastersky, MD, PhD
Jules Bordet Institute
Brussels, Belgium

Per Ljungman, MD, PhD
Karolinska Institute
Stockholm, Sweden

Johan Maertens, MD
University Hospital
Leuven, Belgium

Georg Maschmeyer, MD
Ernst von Bergmann Clinic
Postdam, Germany

Montse Rovira, MD
Hospital Clinic
Barcelona, Spain

Maria Elena Santolaya, MD
Chilean Society of Infection
Santiago, Chile

Jaime Sanz, MD
University Hospital La Fe
Valencia, Spain

Miguel A. Sanz, MD, PhD
University Hospital La Fe
Valencia, Spain

William J. Steinbach, MD
Duke University Medical Center
Durham, North Carolina

Adila Warris, MD
Radboud University Nijmegen Medical Center
Nijmegen, The Netherlands

John R. Wingard, MD
University of Florida
Gainesville, Florida, United States

Friday, 26 January 2007

8:00
Introduction
Jean A. Klastersky, MD, PhD

Session I: Fungal infections in febrile neutropenia: From laboratory and/or clinical diagnosis to preemptive therapy
Chair: Jean A. Klastersky, MD, PhD

8:10
Overview of fungal infections in febrile neutropenic patients (trends in epidemiology, diagnostic accomplishments and challenges, current therapy)
Johan Maertens, MD

8:55
Discussion

9:10
Oral abstract presentations

9:40
Break

10:00
Case presentations
J. Peter Donnelly, PhD
Georg Maschmeyer, MD

11:30
Session chair’s summary
Jean A. Klastersky, MD, PhD

12:00
Luncheon satellite symposium
Supported by MSD

Session II: Different types of transplants, different patterns of infections
Chair: John R. Wingard, MD

13:30
Overview of important viral and other pathogens affecting febrile neutropenic patients (diagnostic accomplishments and challenges, current therapy)
Per Ljungman, MD, PhD

14:15
Discussion

14:30
Oral abstract presentations

15:00
Break

15:20
Case presentations
Hermann Einsele, MD
John R. Wingard, MD

16:50
Session chair’s summary
John R. Wingard, MD

17:20
Adjourn

17:45
Reception
Supported by Pfizer

Saturday, 27 January 2007

Session III: Febrile neutropenia in the pediatric population: Focus on prophylaxis
Chair: Maria Elena Santolaya, MD

8:10
Overview of special issues facing pediatric neutropenic patients, focusing on current efforts and challenges in diagnosis and management
Elio Castagnola, MD

8:55
Discussion

9:10
Oral abstract presentations

9:40
Break

10:00
Case presentations
William J. Steinbach, MD
Adila Warris, MD

11:30
Session chair’s summary
Maria Elena Santolaya, MD

12:00
Luncheon satellite symposium
Supported by Schering-Plough

Session IV: Infectious complications of anticancer strategies
Chair: Miguel A. Sanz, MD, PhD

13:30
Overview of current cancer therapies and therapeutic strategies and their associated infectious complications
Rafael de la Cámara, MD

14:15
Discussion

14:30
Oral abstract presentations

15:00
Break

15:20
Case presentations
Montse Rovira, MD
Jaime Sanz, MD

16:50
Session chair’s summary
Miguel A. Sanz, MD, PhD

17:20
Adjourn

Dear Colleagues,

It is with great pleasure that we invite you to join us for the 9th International Symposium on Febrile Neutropenia. This winter’s symposium in Valencia, Spain, 26-27 January 2007, promises to be our most valuable meeting yet!

The continued growth and success of this international symposium over the past few years has been a true testimony of the need for a meeting focusing on febrile neutropenia. Attendees have offered praise for the quality of the scientific program and the faculty, and they have stated that participation in this conference significantly enhances their knowledge of the implications and management of febrile neutropenia.

This International Symposium is specifically designed for medical oncologists, infectious disease specialists, radiation oncologists, and other healthcare professionals interested and involved in the treatment of patients with febrile neutropenia. Our panel of international experts will touch on the most salient aspects of the etiology, diagnosis, and state-of-the-art management of febrile neutropenia.

Continuing with our successful abstract submissions tradition, we will again be accepting abstracts for both oral and poster presentations. We look forward to reviewing and sharing your research findings with the community.

For this winter’s symposium, we are delighted to be gathering in Valencia, Spain—a city whose cultural and historic importance is felt around the world. We hope you will be able to join us for what is sure to be a rewarding and dynamic experience, as your perspectives and contributions add immeasurable value to this international symposium.

We look forward to seeing you in Valencia!

Jean A. Klastersky, MD, PhD
Chair

Miguel A. Sanz, MD, PhD
Local Chair

Participants interested in presenting data should submit abstracts online at www.imedex.com by 20 December 2006. Abstracts are subject to acceptance by the Scientific Committee. Once accepted, abstracts will be published in the final program book and scheduled for oral or poster presentation.

Acceptance notifications and guidelines for poster presentation will be sent on 3 January 2007. Authors of accepted abstracts who have not registered will have until 12 January 2007 to do so at the discounted rate of € 550. After this date, abstracts without registered presenters will be disregarded.

Submit your abstract online at www.imedex.com.

Abstract Guidelines
• Follow the online instructions
• Abstracts must be written in English
• Accepted format: Word document, 9 point Arial font, 500 word count limit
• Use a concise title
• List affiliations of author(s) as briefly as possible, with city, province and country
• Place an asterisk (*) before the name of the presenting author
• Use standard and well-accepted abbreviations
• When using references, use standard and well-accepted formats
• Abstract content should be single-spaced, typed in lower case and contain:
• Purpose of the study
• Summarized description of the project
• Results and conclusions

Submission Deadline:
20 December 2006
Submission Instructions:
Go to www.imedex.com and click “submit an abstract”

This educational program is specifically designed for medical oncologists, infectious disease specialists, radiation oncologists, and other physicians, physicians-in-training, and healthcare professionals (nurses, pharmacists) interested in and/or involved in the care of patients with febrile neutropenia. No specialized knowledge or skill other than general familiarity with the above disciplines is required for successful participation in this program.

After completion of this activity, participants should be able to:

• Recognize important concepts in the epidemiology and etiology of febrile neutropenia
• Recognize important fungal, bacterial, and viral pathogens affecting patients with febrile neutropenia based on etiology
• Apply current management treatment stratgies for fungal, bacterial and viral infections based on interactive case discussions
• Identify important strategies for diagnosing fungal and viral infections in febrile neutropenic patients
• Evaluate the impact of current anticancer regimens on the incidence, development, and infectious complications of febrile neutropenia

Click here to register for this program

REGISTRATION FEES

Regular . . . . . . . . . . . . . . . . . € 625
If payment received by 17 January 2007

Full/Onsite . . . . . . . . . . . . . . . € 695
If payment received after 17 January 2007

Nurses/Residents/Students* . . . € 200
*Proof of eligibility must accompany registration

To Register
You may register on-line or call Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the international symposium.

To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

Payment
To pre-register, registration and payment must be received no later than 17 January 2007. Please register on-site after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure program is being held as scheduled and to confirm that meeting is not full. Registration fees must be remitted by credit card, check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add € 50 to each wire transaction to cover bank charges. Include the full name of the attendee and the name of the international symposium: 270 Febrile Neutropenia. An attendee is not registered until full payment is received.

Wire to: Bank of America, NA London, 1 Alie Street E1ADE London UK, Swift Code: BOFAGB22, Sort Code: 165050 Beneficiary: Bank of America Domestic Deposit #5687, Account #: 600895687029, Reference: Imedex, Inc. Account # 10726-118, IBAN: GB89 BOFA 1650 5095 6870 29.

Registration Fee Inclusions
Registration fees include admittance to scientific sessions, international symposium materials and all functions as specified in the program.

Cancellation
For registration fees to be refunded, written notice of cancellation must be received at Imedex no later than 17 January 2007. The amount of registration fees remitted, minus a € 90 administrative charge, will be refunded after the international symposium. Substitutions are accepted with written notification. No refunds will be made if notice is received after 17 January 2007.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this international symposium should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The international symposium agenda is subject to change without notice.

Hotel Astoria Palace
Plaza Rodrigo Botet 5
Valencia, Spain
Reservations Tel.: +34 91 594 94 98
Hotel Tel.: +34 96 398 1000
Hotel Fax: +34 96 398 1010

Welcome to Valencia’s most emblematic hotel. The Hotel Astoria Palace owes its prestige to the magnificent quality service provided throughout its history.

The hotel is ideally and centrally located in the heart of the city. Step out of the front door and you are in the midst of the historic centre, the shopping, entertainment and business districts. Manises airport is 8 km away (15 min. by taxi or bus).

Enthralled by its ‘special kind of light,’ Sorolla was to immortalise Valencia’s warmth and colour on canvas. Today, set in the heart of the city in a peaceful, leafy plaza with only the sound of a quietly tinkling fountain, the Hotel Astoria Palace provides first-hand experience of the ‘luminous city.’

For the convenience of attendees, a limited number of rooms have been reserved at a discounted rate of € 115 for single occupancy or € 142 for double occupancy plus tax, currently at 7%. This rate includes daily breakfast buffet. The rate is not guaranteed outside the international symposium dates.

To reserve your room please click here or contact the Hotel Astoria Palace reservations department at +34 91 594 94 98. To receive the group rate, callers must identify themselves as being with the Febrile Neutropenia group. Reservation requests received after 15 January 2007 may not be guaranteed the group rate.

Discounted Airfares
Contact syposium travel agent, Age of Travel, for assistance with your travel needs. Age of Travel can also accommodate pre- and post-symposium extensions.
Tel.: +1 (800) 523 4954 or +1 (404) 591 7120
Email: Imedex@ageoftravel.com

Italian Participants
Fargo International Meetings & Conventions Srl has been appointed as the official agency for government authorization for Italian participants. You may contact them directly at:
Fargo International Meetings & Conventions SRL
Via Piattro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078

Symposium Location and Registration Hours
Hotel Astoria Palace
Plaza Rodrigo Botet 5
Valencia, Spain
Reservations Tel. +34 91 594 94 98
Hotel Tel.: +34 96 398 1000
Hotel Fax: +34 96 398 1010

The Registration and Information Desk will be staffed:
Friday, 26 January 2007 07:00 – 17:00
Saturday, 27 January 2007 07:30 – 16:50

          4325 Alexander Drive
          Alpharetta, GA 30022-3740 USA
          Tel.: +1 (770) 751 7332
          Fax: +1 (770) 751 7334
          Email: meetings@imedex.com
          Web: www.imedex.com